All of the following are related to difficult intubation, except which of the following?
Which anaesthetic agent is contraindicated in patients with emphysema?
In status asthmaticus, which anesthetic agent is used as a bronchodilator?
All are indications for one-lung ventilation except which of the following?
IPPV can cause all of the following complications except:
In infants, the narrowest part of the larynx is at the cricoid level. In administering anesthesia, which of the following is NOT a potential complication of using a smaller size endotracheal tube?
The most common cause of hypoxia during one-lung ventilation is:
What is the medical procedure that involves the insertion of a tube directly into the trachea to secure the airway and ensure adequate ventilation?
In which of the following conditions is Positive end-expiratory pressure (PEEP) beneficial?
What is the intubation dose of pancuronium?
Explanation: ***Increased thyromental distance*** - An **increased thyromental distance** (greater than 6.5 cm) indicates more space between the mental protuberance and the thyroid cartilage, suggesting better laryngeal visualization and thus a **lower likelihood of difficult intubation**. - This measurement correlates with the adequacy of the submandibular space, which is crucial for achieving an optimal sniffing position for intubation. *Miller's sign* - **Miller's sign** refers to a prominent or anterior larynx, which can make it challenging to visualize the glottis during direct laryngoscopy. - This anatomical feature can obstruct the view of the vocal cords, thereby increasing the difficulty of intubation. *TMJ ankylosis* - **Temporomandibular joint (TMJ) ankylosis** significantly restricts mouth opening, which is essential for laryngoscope insertion and laryngeal visualization. - Limited mouth opening is a well-established predictor of **difficult intubation** because it prevents adequate alignment of the oral, pharyngeal, and laryngeal axes. *Micrognathia* - **Micrognathia**, or a small mandible, is associated with a posterior displacement of the tongue and a reduction in the space available for laryngoscope insertion. - This anatomical variation makes it difficult to achieve an adequate view of the glottis and can lead to **difficult or failed intubation**.
Explanation: ***Nitrous oxide (N2O)*** - **Nitrous oxide** diffuses rapidly into air-filled cavities, such as **bullae** in emphysema, causing them to expand. - This expansion can lead to **pneumothorax** or worsen existing respiratory compromise by increasing the size of trapped gas. *Halothane* - While it can cause **bronchodilation**, its use in emphysema is limited due to its potential for **cardiac depression** and **hepatotoxicity**. - It is not specifically contraindicated due to its effect on bullae or air trapping. *Diethyl ether* - This agent is largely obsolete due to its **flammability** and high incidence of **postoperative nausea and vomiting**. - Its effects on emphysematous lungs are less of a concern than its general anesthetic properties and side effects. *Isoflurane* - **Isoflurane** is often preferred in patients with respiratory disease due to its potent **bronchodilating properties** and minimal cardiac depression. - It does not expand air-filled spaces and is considered relatively safe for patients with emphysema.
Explanation: ***Ketamine*** - Possesses **bronchodilatory** properties due to its sympathomimetic effects, making it useful in severe asthma or **status asthmaticus**. - It can cause **catecholamine release**, leading to relaxation of bronchial smooth muscle and improved airflow. *Morphine* - Can cause **histamine release**, which may lead to **bronchoconstriction** and worsen an asthmatic patient's condition. - It is a respiratory depressant that can further compromise breathing in a patient with severe airway obstruction. *Thiopentone sodium* - May induce **histamine release** and cause **bronchospasm**, which is contraindicated in asthma. - It is a potent depressant of the central nervous system and can cause respiratory depression, worsening the clinical picture of status asthmaticus. *Halothane* - Although it has some **bronchodilatory** properties, its use has largely been replaced by newer inhalational anesthetics due to concerns about myocardial sensitization to catecholamines and potential **hepatotoxicity**. - It is a potent inhalational agent but is less favored in modern anesthesia for asthma due to side effect profiles compared to other agents.
Explanation: ***General anesthesia without lung isolation*** - One-lung ventilation (OLV) is specifically performed to achieve **lung isolation**, which is the opposite of general anesthesia without lung isolation. - The goal of OLV is to collapse one lung to facilitate surgical access or prevent contamination, making general anesthesia without isolation a contraindication. *Bronchopleural fistula* - OLV is indicated in cases of **bronchopleural fistula** to prevent leakage of air from the affected lung into the intact lung. - This helps to maintain adequate ventilation and oxygenation in the healthy lung while the fistula can be managed or repaired. *Massive hemorrhage in one lung* - **Massive hemorrhage** in one lung is a critical indication for OLV to prevent the spread of blood to the contralateral healthy lung. - Isolating the bleeding lung protects the airway and facilitates surgical control of the hemorrhage. *Video-assisted thoracoscopic surgery* - **Video-assisted thoracoscopic surgery (VATS)** procedures frequently require OLV to collapse the operative lung. - This provides a clear surgical field and sufficient working space for the surgeon to perform the procedure without lung movement obstructing the view.
Explanation: **Pulmonary embolism** - **Mechanical ventilation**, particularly intermittent positive pressure ventilation (IPPV), is not a direct cause of pulmonary embolism. - While prolonged immobility and venous stasis in critically ill patients can increase the risk of deep vein thrombosis (DVT) and subsequent PE, IPPV itself does not directly induce thrombus formation. *Barotrauma* - **High inspiratory pressures** and large tidal volumes used during IPPV can overdistend alveoli, leading to rupture and air leaks. - This can result in conditions like **pneumothorax**, **pneumomediastinum**, and **subcutaneous emphysema**. *Pneumonia* - IPPV is a significant risk factor for **ventilator-associated pneumonia (VAP)** due to the presence of an endotracheal tube. - The tube bypasses natural airway defenses, facilitating bacterial colonization and aspiration of secretions. *Hypotension* - Positive pressure applied during IPPV can increase **intrathoracic pressure**, which in turn reduces venous return to the heart. - This decrease in preload directly leads to a **reduction in cardiac output** and systemic blood pressure, causing hypotension.
Explanation: ***Choosing a smaller size endotracheal tube*** - This option incorrectly states that *choosing a smaller size endotracheal tube* is a complication. It is a decision or action, not a direct complication of the tube itself. - While an *appropriately* sized smaller tube can be beneficial, the act of *choosing* it isn't inherently a complication. *Trauma to the subglottic region* - Using an **overly *large* endotracheal tube** can cause trauma to the **subglottic region**, which is the narrowest part of an infant's airway. - Trauma can lead to **edema**, **ulceration**, or even **scarring**, potentially resulting in **subglottic stenosis**. *Increased risk of airway obstruction* - An **endotracheal tube (ETT) that is too *small*** for the child can lead to various issues, including an **increased risk of obstruction** due to secretions or kinking. - A tube that is too small also offers higher resistance to airflow, making adequate ventilation more challenging and potentially requiring higher pressures. *Choosing an inappropriate size endotracheal tube* - *Choosing an inappropriate size endotracheal tube*, whether too large or too small, is a **patient safety concern** that can lead to various complications. - An **incorrectly sized tube** can result in complications ranging from air leak and inadequate ventilation (if too small) to direct airway trauma and post-extubation stridor (if too large).
Explanation: ***Malposition of the double-lumen tube*** - **Malposition** of the double-lumen tube can lead to **obstruction of airflow** to the ventilated lung or incomplete isolation of the non-ventilated lung, resulting in significant **ventilation-perfusion mismatch** and **hypoxia**. - Incorrect placement is a common and often immediate cause of hypoxemia during one-lung ventilation because it directly interferes with the intended strategy of isolating and ventilating one lung while collapsing the other. *Increased shunt fraction* - While an **increased shunt fraction** is the physiological mechanism explaining hypoxia during one-lung ventilation, it is the *result* of various causes, not the primary cause itself. - The shunt fraction increases naturally due to blood flow through the non-ventilated lung, but a *pathological* increase causing severe hypoxia suggests another underlying problem like inadequate hypoxic pulmonary vasoconstriction or malposition of the tube. *Collapse of one lung* - The **collapse of one lung** is an *intended outcome* of one-lung ventilation to facilitate surgical access, and by itself, it is not the most common *cause* of hypoxia. - While collapse contributes to shunt, the body normally compensates through **hypoxic pulmonary vasoconstriction**; severe hypoxia typically points to a failure of this compensation or other issues. *Soiling of lung by secretions* - **Soiling of the lung by secretions** can certainly cause hypoxia by obstructing airways and increasing shunt but is **less common** than issues related to tube placement. - This typically causes **sudden deterioration** and requires immediate suctioning, but malposition is a more frequent initial problem during setup or with patient movement.
Explanation: ***Endotracheal tube insertion*** - This procedure involves placing a tube directly into the **trachea** to maintain an open airway and facilitate **mechanical ventilation**. - It is critical for patients who cannot protect their airway or require ventilatory support, ensuring direct access for gas exchange. *Oral suction* - **Oral suction** involves removing secretions from the mouth and pharynx but does not secure the airway to prevent aspiration or provide direct ventilatory support. - It is a superficial procedure, used for clearing the oral cavity, not for managing the trachea. *Oropharyngeal suction* - Similar to oral suction, **oropharyngeal suction** clears the back of the throat but does not involve insertion into the trachea to secure the airway. - This method is used for removing secretions from the upper airway and preventing aspiration into the larynx, but it doesn't establish a definitive airway. *Nasogastric tube insertion* - **Nasogastric tube insertion** involves placing a tube through the nose into the stomach, primarily for feeding or gastric decompression. - This procedure is unrelated to airway management and has no role in securing the trachea for ventilation.
Explanation: ***Acute Respiratory Distress Syndrome (ARDS)*** - PEEP is crucial in ARDS to prevent **alveolar collapse** at end-expiration, improving oxygenation and reducing the risk of **ventilator-induced lung injury**. - It helps by **recruiting collapsed alveoli** and maintaining them open, thus increasing the functional residual capacity. *Pneumonia* - While pneumonia can cause hypoxemia, PEEP's benefit is less pronounced unless it progresses to **ARDS** or causes significant **atelectasis**. - Excessive PEEP can lead to barotrauma if lung compliance is relatively normal or if only a limited portion of the lung is affected. *Pulmonary edema* - PEEP can be helpful in **cardiogenic pulmonary edema** by reducing venous return and thus **preload**, as well as improving oxygenation. - However, it's not the primary or most universally beneficial intervention compared to its role in ARDS. *Chronic Obstructive Pulmonary Disease (COPD)* - PEEP must be used cautiously in COPD due to the risk of **dynamic hyperinflation** and **auto-PEEP**, which can increase air trapping. - While it might be cautiously applied to improve oxygenation or reduce work of breathing, it's generally not considered broadly beneficial and can be detrimental if not carefully managed.
Explanation: ***0.08 mg/Kg*** - The standard **intubating dose** of pancuronium is typically **0.08-0.1 mg/kg intravenously**. - This dose provides adequate **neuromuscular blockade** for endotracheal intubation. *0.02 mg/Kg* - This dose is too low and would likely result in **insufficient neuromuscular blockade** for successful intubation. - Sub-therapeutic doses would lead to **incomplete muscle relaxation**, making intubation difficult and risky. *0.04 mg/Kg* - While higher than 0.02 mg/kg, this dose is still generally considered **sub-optimal** for intubation with pancuronium. - It may prolong the onset of action or provide **inadequate depth of block** for optimal intubating conditions. *0.06 mg/Kg* - This dose is approaching the lower end of an effective range for some neuromuscular blocking agents, but it is typically **not sufficient** for reliable intubation with pancuronium. - It might lead to a longer **onset time** and compromised intubating conditions compared to the recommended dose.
Respiratory Physiology
Practice Questions
Airway Anatomy
Practice Questions
Preoxygenation Techniques
Practice Questions
Mask Ventilation
Practice Questions
Supraglottic Airway Devices
Practice Questions
Direct Laryngoscopy
Practice Questions
Video Laryngoscopy
Practice Questions
Fiberoptic Intubation
Practice Questions
Surgical Airway Management
Practice Questions
One-Lung Ventilation Techniques
Practice Questions
Ventilation Strategies During Anesthesia
Practice Questions
Extubation Criteria and Techniques
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free